Phase i study of 'dose-dense' pemetrexed plus carboplatin/radiotherapy for locally advanced non-small cell lung carcinoma

BACKGROUND: This phase I study investigates the feasibility of carboplatin plus dose-dense (q2-week) pemetrexed given concurrently with radiotherapy (XRT) for locally advanced and oligometastatic non-small cell lung cancer (NSCLC). METHODS: Eligible patients had Stage III or IV (oligometastatic) NSC...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Xinglei, DeNittis, Albert, Werner-Wasik, Maria, Axelrod, Rita, Gilman, Paul, Meyer, Thomas, Treat, Joseph, Curran, Walter J, Machtay, Mitchell
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3050732/
https://www.ncbi.nlm.nih.gov/pubmed/21324160
http://dx.doi.org/10.1186/1748-717X-6-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3050732/
https://www.ncbi.nlm.nih.gov/pubmed/21324160
http://dx.doi.org/10.1186/1748-717X-6-17

Ejemplares similares